he coronary bare metal stent (BMS) system decreases the incidence of restenosis in the convalescent phase, in addition to preventing the occurrence of an acute occlusion immediately following percutaneous coronary intervention (PCI). 1,2 However, 15% patients require repeat PCI due to in-stent restenosis. To resolve this issue, drug-eluting stents (DES) were developed and a sirolimus-eluting stent (SES) has started to be used in the clinical setting. Several clinical trials have shown a greater reduction in the incidence of in-stent restenosis with this system compared with a BMS, 3-7 and the use of DES has spread rapidly.
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However, it has been noted that, following DES implantation, there is delayed healing of the vessel wall, together with inhibition of neointimal hyperplasia (NIH) and continuation of the inflammation response; these phenomena have led to concerns about the possible increased risk of stent thrombosis during the convalescent phase. Indeed, 4 cases of very late stent thrombosis, 1 year after DES implantation, have been reported; 8 a previous study has demonstrated that the rate of stent thrombosis gradually increased by 0.2-0.6%/year. 9 An experimental animal model has shown a continuous inflammatory response (IR) in NIH and the vessel wall after DES implantation compared with BMS and, moreover, it has been demonstrated that late malapposition and the invasion of inflammatory cells occur in the peri-stent area in postmortem cases with evidence of stent thrombosis, suggesting that there is a causal relationship among stent thrombosis and late malapposition and vessel inflammation response. [10] [11] [12] Optical coherence tomography (OCT) is a recently developed invasive and intravascular diagnostic imaging modality that emits near infrared rays from optical fibers, which are
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used to analyze the differences between the control beam and reflected beam. 13 The OCT image has a high resolution of approximately 10-20 μm, which is 10-fold higher than that of intravascular ultrasound (IVUS: 100-200 μm).
OCT is superior to IVUS for the study of the intraluminal morphology of the coronary artery, and it can easily detect stent malapposition, the thickness of NIH and intramural thrombi, none of which can be visualized by IVUS. 14-22 Moreover, OCT can reportedly detect and quantify the number of inflammatory cells present, including macrophages in the coronary artery plaque. 23 However, it is unknown whether it can successfully be used in vivo to detect inflammatory changes after stenting in patients with coronary artery disease.
The purpose of this study was to evaluate the morphological and IR in NIH, including in the vessel wall, by means of quantitative and characteristic analysis using the OCT system, in order to compare SES implantation with the BMS system.
Methods

Patients
From February 2008 to February 2010, a total of 37 patients with chronic coronary artery disease after coronary stenting were eligible for inclusion in this study. Of the 37 patients enrolled in the study, 13 had BMS and 24 had SES. We excluded patients with acute coronary syndrome after emergency coronary intervention or with in-stent restenosis. Written informed consent was given by each patient. The study protocol was approved by the Ethics Committee of the Iwate Medical University.
Coronary Angiography, IVUS and OCT Imaging
We performed follow-up coronary angiography, 6-10 months after elective stent implantation, which was performed according to Judkin's technique via the transradial approach with a 6Fr system. After insertion of a 0.36-mm intervention guide wire, IVUS imaging was performed using 6Fr guiding catheter. The pull-back speed of the IVUS transducer from the distal end to the target lesion was 0.5 mm/s. A conventional IVUS system was used (Atlantis Pro-2 and Galaxy-2 system; Boston Scientific, Natick, MA, USA). Conventional IVUS images were acquired using a 40-MHz mechanically rotating IVUS catheter.
Following IVUS imaging, OCT imaging was performed during occlusion of the proximal coronary artery with a compliant balloon (4Fr occlusion balloon catheter, Helios, LightLab Imaging, Westford, MA, USA) and continuous flushing. The fluid flush comprised 1 part Dextran 40 to 3 parts lactated Ringer's solution. A 0.016-inch OCT catheter was used (Image Wire, LightLab Imaging). We evaluated the peristent staining phenomenon (PSS) in coronary angiography. The evaluation of PSS was performed by experienced staff (T.I.) who was unaware of the type of implanted stent. Peripheral blood sampling for the evaluation of high-sensitivity C-reactive protein (hs-CRP) was obtained from each patient at admission before OCT imaging, which was performed the next day after sampling.
Quantitative Coronary Angiography (QCA) and IVUS Analysis
The target lesion was analyzed using QCA on a QCA-CMS system (version 5.3xx, MEDIS Medical Imaging Systems, Leiden, The Netherlands). Lesion analyses by IVUS were performed using the measurement software Echo Plaque-2 system (Indec, Santa Clara, CA, USA). All IVUS analyses were performed in a blind fashion by an experienced staff member (I.G.).
OCT Imaging Analysis
Cross-sectional in-stent OCT images were analyzed at 1-mm intervals. The thickness of NIH was measured inside all struts of the stent. Figures 1 and 2 show representative cases in both groups. The following were evaluated: malapposition rate [(number of malapposition struts/number of evaluated stent struts) ×100], uncovered stent strut rate [rate of uncovered strut by NIH; (number of uncovered stent strut/number of evaluated stent struts) ×100], peri-stent ulcer-like appearance rate (PSUA: number of patients with PSUA/total number of patients), rate of in-stent thrombus (number of patients with in-stent thrombus/total number of patients) and micro channels (number of patients with micro channel/total number of patients). Maximum distance between the inner strut surface and the adjacent vessel surface greater than the thickness of the stent strut and polymer (thickness + 20 μm: 166 μm for SES) was defined as malapposition. PSUA was defined as a hollow shape (>90 degrees/1 frame) in the vessel wall adjacent to the stent strut, and present in at least 3 contiguous frames. Micro channel in NIH was defined as a microscopic, low-intensity round lumen with no connection with the vessel lumen in at least 3 contiguous frames.
Corrected OCT images were converted to raw data and a region of interest (ROI) was set up in NIH at an interval of 30 frames, using 3 points to randomly designate the ROI. In the PSUA site, the ROI was set up in the vascular wall between the stent struts. Figure 3 shows an example of how this measurement was performed, and shows the designation of the ROI in the NIH of a raw data image. OCT images were processed and analyzed with appropriate software (NIH Image J National Institutes of Health, Bethesda, MD, USA). We computed the normalized standard deviation (NSD), which was calculated as the signal intensity deviation of NIH, corrected for background image. Image signal intensity standard deviation (SD) was normalized by the difference between the maximum and minimum OCT signals present in the OCT raw image as follows: NSD = SD/(S max. -S min.).
Statistical Analysis
Data are presented as mean ± SD. Comparison of means between the 2 groups was performed with the unpaired t-test and Mann-Whitney U-test. Statistical comparison of the differences in categorical data between the 2 groups was performed using the chi-square test. Differences were considered significant at P<0.05. Correlation analysis between hs-CRP and OCT-NSD was done after converting to the log value. All statistical analysis was performed using SPSS II for Windows (Chicago, IL, USA). Table 1 shows the baseline clinical characteristics of the patients. Prescription of thienopiridine in the SES group was significantly higher than in the BMS group (P=0.03). Average NIH thickness in the SES group was significantly less than in the BMS group (0.08±0.03 mm vs. 0.35±0.17 mm, P<0.0001; Figure 4 ). The number of evaluated stent struts was 3,755 for the SES group and 1,031 for the BMS group. Stent malapposition rate (1.78% vs. 0.7%; P=0.016), uncovered stent strut rate (16.0% vs. 3.7%; P=0.0002), peri-stent ulcer like appearance (50% vs. 0%; P=0.006) were, respectively, all significantly higher in the SES group than in the BMS group ( Table 2) . We examined the relation between stent length and PSUA, in-stent thrombus and micro-channels, but there was none between stent length and these factors.
Moreover, the OCT-NSD value was significantly higher in the SES group than in the BMS group (0.213±0. Figure 5 . Comparison of OCT-NSD values and hs-CRP levels. These levels were significantly higher in the SES group than in the BMS group. BMS, bare metal stent; hs-CRP, high-sensitivity C-reactive protein; OCT-NSD, optical coherence tomography signal-intensity normalized standard-deviation; SES, sirolimus-eluting stent. GOTO I et al.
addition, a significant positive correlation was found between hs-CRP and NSD-OCT (r=0.471, P=0.0025; Figure 6 ). In addition, we evaluated the difference between the NSD-OCT values and hs-CRP levels according to lesion characteristics in both groups. The SES group was divided into 2 subgroups according to lesion length of >20 mm and ≤20 mm. However, there were no significant differences between these 2 groups in terms of OCT-NSD (0.215±0.004 vs. 0.213±0.006, P=0.81) and hs-CRP value (2.71±1.9 mg/L vs. 2.33±1.7 mg/L, P=0.71). The SES group was also divided into 2 subgroups according to vessel size ≥3.0 mm and <3.0 mm, but there was also no significant differences between the 2 groups in terms of OCT-NSD (0.214±0.006 vs. 0.212±0.007, P=0.68) and hs-CRP value (2.68±2.1 mg/L vs. 2.29±1.9 mg/L, P=0.74).
Moreover, we evaluated the OCT-NSD and hs-CRP value after dividing the SES patients into 2 subgroups according to the presence or absence of PSUA. Again, there were no significant differences between the 2 groups in terms of OCT-NSD (0.213±0.005 vs. 0.2132±0.004, P=0.91) and hs-CRP value (2.74±2.1 mg/L vs. 2.31±1.5 mg/L, P=0.71).
Discussion
Using OCT images, we evaluated in-stent NIH after elective stent implantation in patients during the convalescent phase of treatment for chronic coronary artery disease. We evaluated not only 2D analysis, such as NIH thickness, but also the IR using the OCT-NSD value, and compared the BMS and SES groups. The thickness of NIH in the SES group was significantly less than in the BMS group; some SES cases had PSUA, malapposition, and uncovered stent struts. Moreover, the OCT-NSD values in NIH and the hs-CRP concentrations in the SES group were both significantly higher than in the BMS group. These results suggest a greater IR in NIH, in addition to exposure of the stent strut and warped unevenness of the vessel wall, after SES implantation than after BMS. These results are thought to reflect the risk for stent thrombosis after SES implantation, which has been reported previously by pathological examination.
Examination of Stent Coverage by OCT
There has been a rapid increase in the use of DES in the clinical setting. However, this new technique has prompted discussion on the possibility of an abnormal tissue response in the vessel wall after DES implantation; it is recognized that this is a potentially new and important problem and one that was never considered in the BMS era. For example, the cause of late-or very-late stent thrombosis after DES implantation during the convalescent phase is not well understood, but recently, late malapposition, uncovered stent struts, and positive vessel remodeling have been identified, by IVUS and OCT analysis, as latent factors after DES implantation. [24] [25] [26] [27] [28] [29] In the present study, the rate of malapposition and uncovered stent struts in the SES group was significantly higher than in the BMS group. The RESTART study, which examined stent thrombosis after SES implantation, showed that PSS visualized by coronary angiography (suggesting late malapposition) relates to very-late stent thrombosis. 30 It is thought that some cases of PSS develop stent thrombosis or coronary aneurysm. 31 Moreover, Morino et al reported a relationship between PSS findings by coronary angiography and PSUA by OCT. 32 In the present study, the incidence of finding PSUA, which is suggested as a pre-PSS stage, by OCT was 50% in the SES group. Coronary angiography demonstrated PSS (nearly equal to late malapposition and PSUA) in some cases; however, the RESTART study reported PSS findings in only 35% cases, while late malapposition findings, which could not be visualized by coronary angiography, may have been present in the other 65% cases. OCT could be used to predict PSUA earlier, as a pre-late malapposition stage that can not be visualized by coronary angiography.
Evaluation of Inflammatory Cell Invasion by OCT
A previous study reported that OCT could detect and quantify the presence of inflammatory cells, such as macrophages, in coronary artery plaque. 23 In that study, OCT showed several strong light-intensity backscatter reflections in the fibrous cap, and the signal revealed extensive deviation. As a result, the authors showed that the occupation rate of the CD68-positive area significantly correlated with the OCT-NSD value. 23 Their report suggests that OCT image analysis could be used to evaluate the accumulation of macrophages in the fibrous cap covering the lipid plaque. We measured the OCT-NSD value in NIH tissue after stenting and showed that the value Figure 6 . Correlation between log hs-CRP and log OCT-NSD. Blue dots indicate the bare metal stent group. Pink dots indicate the sirolimus-eluting stent group. hs-CRP, high-sensitivity C-reactive protein; OCT-NSD, optical coherence tomography signal-intensity normalized standard-deviation. Vascular Response After SES Evaluated by OCT in the SES group was significantly higher than in the BMS group. The OCT-NSD value, which reflects at least the presence of cell components such as macrophages, could distinguish macrophage-rich NIH from regular NIH after BMS implantation. In this regard, we considered that NIH after SES implantation showed an increased inflammatory reaction, because hs-CRP in the SES group was significantly higher compared to the BMS group and because the serum hs-CRP level was significantly correlated with the OCT-NSD-value. In the present study, it is unlikely that the formation of PSUA was caused only by an IR, because the presence of PSUA was not related to the severity of inflammation based on the OCT-NSD value and hs-CRP level. Evaluation of the site after coronary stent implantation using OCT appears to provide not only precise anatomical information, but also information on the IR of the stented vessel.
Study Limitations
First, our study was not a randomized trial for implantation of stents, but rather an observational study. Second, it was difficult to detect the vessel response in the deeper layers because OCT visualization only penetrated to a depth of 1-2 mm in the vessel wall. The nature of the inflammatory changes in the deep tissue layers of a stented coronary artery is unknown. Thirdly, the non-specificity for hs-CRP in this study is an open question. The hs-CRP level is a reflection of several systemic inflammation responses. However, in the present study, hs-CRP levels suggested an inflammation response in NIH, because the hs-CRP levels positively correlated with the OCT-NSD value. Fourth, the ROI setting have not been established yet. We evaluated the size and morphology of ROIs by preliminary analysis. The ROI values obtained from the 2 shapes (rectangle vs. circle) were similar (r=0.930, P<0.0001). Moreover, a direct relationship was found between 2 sizes (1 vs. 2 mm) of ROI (r=0.895, P<0.0001). As a result, the OCT-NSD value is not affected by the ROI setting and was nearly equal in these settings.
Conclusions
PSUA morphology was specific in the SES group, and higher levels of OCT-NSD and hs-CRP after SES implantation suggest a sustained inflammatory change in NIH compared with BMS implantation. These different characteristics may be some of the background that promotes thrombus formation as a late-stage post-stent complication of SES.
